Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2
SPIRIVA RESPIMAT, 1
Children—Use and dose must be determined by your doctor
20 and $2
INDICATIONS
COPD includes chronic bronchitis and emphysema